that invest in research and development,
focus on innovation and have their eye on
the international market are the types of
organizations that flourish inside the com-
munity.
MEDICAGO IS A QUEBEC
ECOSYSTEM SUCCESS STORY
One such success story is Medicago,
which develops vaccines and therapeu-
tic proteins using an exclusive production
process based on the genetic engineer-
ing of plants. The company, which began
years ago as a small group of researchers,
attracted international attention and was
eventually acquired in 2013 by Japan-based
Mitsubishi Tanabe Pharma. Last fall, the
company was awarded a contract by the
Public Health Agency of Canada to devel-
op two antibodies to fight the Sudan strain
of the Ebola virus. BD Diagnostics is an-
other successful business within the Park,
hiring hundreds of employees and making
substantial investments in the community,
Ms Quirion said.
Another startup, B-TEMIA Inc., is a pri-
vate medical device company specializing
in human augmentation systems, which
work to enhance and preserve human mo-
bility and independence. The market is a
growing one, projected to be worth close
to $675 million by 2020. Last November,
B-TEMIA initiated a clinical trial aimed at
demonstrating the benefits and safety for
home use of its Keeogo technology, a pow-
MARCH 2016
H
business elite canada
9
